More than 70 registered nurses, members of the Ontario Nurses' Association (ONA), reached a new collective agreement with Southwestern Public Health (SWPH) during a round of conciliation that ...

Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea (OSA) and other ...

Acquired resistance genes may allow bacteria to degrade or chemically modify antibiotics, rendering them ineffective. They ...

Caught episode 4 sees the mystery surrounding Martina's murder deepen as a shocking new suspect comes to light.

‘There isn’t a cure for herpes, which means you may get outbreaks again in the future. These are often less sever and don’t last as long as the initial outbreak. They can sometimes be triggered when ...

Morgan Stanley analyst Daniel Kutz lowered the firm’s price target on Patterson-UTI (PTEN) to $9 from $10 and keeps an Equal Weight rating on ...

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

RBC Capital analyst Keith Mackey maintained a Buy rating on Patterson-UTI (PTEN – Research Report) yesterday and set a price target of $11.00.

You can have a field day with this home — literally. Mike Pouncey, once a standout center on the Miami Dolphins and the Los Angeles Chargers, is set to list his expansive Fort Lauderdale ...

With a strong recommendation that Justin Baldoni and his team catch up on California law, Blake Lively wants the latest version of her It Ends With Us co-star’s $400 million defamation and ...